Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Return on Assets (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Return on Assets for 15 consecutive years, with 2.05% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 126.0% year-over-year to 2.05%, compared with a TTM value of 2.05% through Sep 2025, down 126.0%, and an annual FY2024 reading of 0.93%, up 12.0% over the prior year.
  • Return on Assets was 2.05% for Q3 2025 at BioRestorative Therapies, down from 1.39% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.75% in Q1 2022 and bottomed at 9.15% in Q3 2021.
  • Average Return on Assets over 5 years is 2.01%, with a median of 1.15% recorded in 2023.
  • The sharpest move saw Return on Assets crashed -649bps in 2021, then skyrocketed 817bps in 2022.
  • Year by year, Return on Assets stood at 2.14% in 2021, then surged by 48bps to 1.11% in 2022, then fell by -4bps to 1.15% in 2023, then grew by 25bps to 0.86% in 2024, then plummeted by -138bps to 2.05% in 2025.
  • Business Quant data shows Return on Assets for BRTX at 2.05% in Q3 2025, 1.39% in Q2 2025, and 1.08% in Q1 2025.